Philips

For many years, innovation in MRI has been measured primarily by performance: image quality, clinical confidence, speed and the ability to support increasingly complex diagnostic needs. Those priorities remain essential. But for imaging leaders today, another question is important: how resilient is this technology when conditions aren’t ideal?

That question is no longer theoretical. Health systems are operating in an environment where disruption can come from many directions: infrastructure failure, severe weather, power outages, supply chain constraints or geopolitical instability. When MRI capacity goes down, the effects are immediate. Hospitals can lose access to critical diagnostic tools, meaning patients may face delayed diagnoses and staff may be forced to adjust care pathways.

For health systems, MRI resilience should be measured not only by what a scanner can do in ideal conditions, but by how quickly it can help sustain access to care when conditions are disrupted.

This is especially consequential in a world where access to MRI remains uneven. If an MRI system is down for two weeks, as many as 1,000 patients may not be scanned, of which ten percent could have a critical finding requiring immediate care (FP Analytics + Philips). In that context, MRI resilience is not just an equipment-planning issue: it’s an access-to-care issue.

The New Resilience Challenge in MRI

Healthcare resilience can no longer be reactive. The ability to maintain essential services during disruption, and restore them quickly afterward, must be considered proactively.

In imaging, this means looking beyond traditional performance metrics and evaluating the technology’s full operational profile: resource dependencies, shutdown and restart requirements, staffing, service, logistics and cost.

These considerations matter because MRI is so deeply connected to broader care delivery. For both patients and clinicians, the impact is tangible: a delay in imaging can affect diagnosis, treatment planning, patient throughput and downstream clinical decisions. Uptime is not simply a technical metric; it is a continuity-of-care issue.

Helium Dependency as an Operational Risk

One area where resilience has become especially important is helium dependency.

Traditional MRI systems rely on large volumes of helium to cool their magnets. Helium is a finite, non-renewable resource with a supply chain concentrated in a limited number of countries. For healthcare providers, this creates exposure to price volatility, logistics challenges and supply disruption.

The larger question, then, is whether an essential imaging service should remain highly dependent on a scarce and complex resource over the long term.

This is where helium-free MRI has an increasingly important role to play. By reducing reliance on helium, health systems can reduce a key operational vulnerability in their imaging infrastructure.

Designing Resilience into Imaging Infrastructure

Philips introduced BlueSeal, pioneering helium-free MRI technology in 2018 to help address this challenge. The technology requires just 7 liters of helium in a fully sealed magnet, compared with roughly 1,500 liters in a conventional MRI system and removes the need for helium refills.

“MRI resilience should be measured not only by what a scanner can do in ideal conditions, but by how quickly it helps sustain access to care when conditions are disrupted.”

That reduction is meaningful both from a sustainability and operational standpoint. A sealed magnet design helps reduce exposure to helium supply constraints, refill logistics and helium-related cost pressures. It can also support simpler installations and restart processes after shutdown events, helping care teams restore access to imaging more quickly.

In real-world disruption scenarios, including major infrastructure and power-related events in Spain and Portugal in 2024, these design considerations have shown why resilience matters. The goal is not only to withstand disruption, but to help health systems recover more efficiently – optimizing access to care for patients.

The faster an imaging service can return to normal operations, the faster care teams can resume exams, reducing scheduling bottlenecks and helping patients continue their diagnostic or treatment journey.

Since 2018, Philips has installed more than 2,500+ BlueSeal systems globally, saving more than six million liters of helium compared with conventional magnet manufacturing. That experience demonstrates resilience in MRI is not only a future aspiration, but it is already becoming part of how health systems evaluate imaging infrastructure.

What Health Systems Should Consider Next

Of course, MRI resilience is not only about helium. It also depends on service models, energy efficiency, installation requirements, continuity planning, remote support, fleet management and the ability of technology partners to help protect uptime across the imaging enterprise.

For imaging leaders, the opportunity is to broaden the definition of innovation. Clinical performance will always be central, but performance in ideal conditions is no longer enough. Health systems also need technology that can support better care for more people when conditions are uncertain, resources are constrained or infrastructure is under pressure. That need will become more urgent as global demand for MRI systems is expected to grow by seven percent annually, increasing pressure on health systems to expand imaging capacity while reducing dependency on scarce resources (FP Analytics + Philips).

This shift has implications for purchasing, planning and long-term imaging strategy. Leaders should evaluate MRI systems not only by image quality and throughput, but also by operational dependencies, recovery requirements, total cost of ownership and resilience over the life of the system.

The future of MRI will be shaped by technologies like helium-free options that combine clinical confidence with operational durability. In my view, that is where the next chapter of imaging innovation is headed: toward systems designed not only to perform, but to endure.